AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33060543 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascularized composite allografts
Number of subjects: 0
Study 33060543 — intervention group
Group type: EXPERIMENTAL
Intervention: Consensus data sets
Number of subjects: 0
Study 33060543 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative efforts by field experts
Number of subjects: 0
Study 34347623 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined age at menarche
Number of subjects: 0
Study 34347623 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined age at menopause
Number of subjects: 0
Study 34347623 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at menarche
Number of subjects: 0
Study 35405480 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate self-reported coffee consumption
Number of subjects: 114551
Study 35405480 — intervention group
Group type: EXPERIMENTAL
Intervention: High genetically predicted coffee consumption
Number of subjects: 114551
Study 35405480 — intervention group
Group type: EXPERIMENTAL
Intervention: High self-reported smoking
Number of subjects: 114551
Study 35405480 — intervention group
Group type: EXPERIMENTAL
Intervention: High genetically predicted smoking
Number of subjects: 114551
Study 33550995 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdiagnostic psychological therapy (n = 527)
Number of subjects: 1061
Study 33550995 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) (n = 534)
Number of subjects: 1061
Study 35984511 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated humidified high-flow nasal cannula (HFNC) oxygen therapy
Number of subjects: 60
Study 35984511 — intervention group
Group type: COMPARATOR
Intervention: Traditional nasal catheter oxygen therapy
Number of subjects: 60
Study 34217960 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of echinacea angustifolia, twice daily
Number of subjects: 108
Study 34217960 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of echinacea angustifolia, twice daily
Number of subjects: 108
Study 34217960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study 36394873 — intervention group
Group type: EXPERIMENTAL
Intervention: PreVenture intervention
Number of subjects: 438
Study 36394873 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 438
Study 33168881 — intervention group
Group type: EXPERIMENTAL
Intervention: enrofloxacin (ENR)
Number of subjects: 67
Study 33168881 — intervention group
Group type: EXPERIMENTAL
Intervention: tulathromycin (TUL)
Number of subjects: 67
Study 33168881 — intervention group
Group type: COMPARATOR
Intervention: no treatment (CTL)
Number of subjects: 67
Study 36472990 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural mobilization
Number of subjects: 88
Study 36472990 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 88
Study 33000332 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (High-Intensity Interval Training)
Number of subjects: 22
Study 33000332 — intervention group
Group type: COMPARATOR
Intervention: MICT (Moderate Intensity Continuous Training)
Number of subjects: 22
Study 33000332 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 22
Study 33000332 — intervention group
Group type: COMPARATOR
Intervention: MICT
Number of subjects: 22
Study 32681775 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological support for group a (on strict diet)
Number of subjects: 60
Study 32681775 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological support for group b (on loos diet)
Number of subjects: 60
Study 32681775 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological support for group c (off diet)
Number of subjects: 60
Study 33675793 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal estradiol
Number of subjects: 120
Study 33675793 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisturizer
Number of subjects: 120
Study 33675793 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual placebo
Number of subjects: 120
Study 32401086 — intervention group
Group type: EXPERIMENTAL
Intervention: IANB with additional buccal infiltration
Number of subjects: 120
Study 32401086 — intervention group
Group type: COMPARATOR
Intervention: Buccal and lingual anaesthetic infiltration (INF)
Number of subjects: 120
Study 35615800 — intervention group
Group type: EXPERIMENTAL
Intervention: ALND+ DEPART
Number of subjects: 265
Study 35615800 — intervention group
Group type: COMPARATOR
Intervention: Standard ALND
Number of subjects: 265
Study 33009991 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSAAF program
Number of subjects: 346
Study 35527116 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34820147 — intervention group
Group type: EXPERIMENTAL
Intervention: SpHb monitoring
Number of subjects: 150
Study 34820147 — intervention group
Group type: COMPARATOR
Intervention: Control group (surgeons’ experience)
Number of subjects: 150
Study 35151559 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular midazolam
Number of subjects: 0
Study 35151559 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular haloperidol
Number of subjects: 0
Study 35151559 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular olanzapine
Number of subjects: 0
Study 34453212 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative intravenous somatostatin (250 μg/h over 120 h); n=99
Number of subjects: 199
Study 35785965 — intervention group
Group type: COMPARATOR
Intervention: Guideline-based regular exercise (EXE)
Number of subjects: 47
Study 35785965 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-based regular exercise and 15-minute post-exercise sauna (EXS)
Number of subjects: 47
Study 34278884 — intervention group
Group type: EXPERIMENTAL
Intervention: 3NB (combined suprascapular, axillary nerve, and the articular branch of lateral pectoral nerve block)
Number of subjects: 85
Study 34278884 — intervention group
Group type: COMPARATOR
Intervention: ISB (interscalene nerve block)
Number of subjects: 85
Study 34278884 — intervention group
Group type: EXPERIMENTAL
Intervention: 3NB
Number of subjects: 85
Study 34010221 — intervention group
Group type: EXPERIMENTAL
Intervention: Capillary pull technique
Number of subjects: 118
Study 34010221 — intervention group
Group type: COMPARATOR
Intervention: Suction technique
Number of subjects: 118
Study 34941128 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mL of a 2% saline solution for bilateral nasal irrigation for 1 week, followed by 50 mL of a 0.9% normal saline solution for bilateral nasal irrigations.
Number of subjects: 60
Study 34941128 — intervention group
Group type: COMPARATOR
Intervention: Routine guidance and 20 mL of normal saline atomized through inhalation.
Number of subjects: 60
Study 36271928 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (anode F3 and cathode F4; 2 mA intensity) and an action-like video game
Number of subjects: 114
Study 36271928 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS and a control video game
Number of subjects: 114
Study 33413355 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 42
Study 33413355 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 34045632 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone method (20 s of ozone from the healozone X4)
Number of subjects: 84
Study 34045632 — intervention group
Group type: COMPARATOR
Intervention: Traditional method (complete caries removal)
Number of subjects: 84
Study 36099230 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilute Silver Diamine Fluoride (1:10)
Number of subjects: 56
Study 36099230 — intervention group
Group type: COMPARATOR
Intervention: Light Cure Calcium Hydroxide
Number of subjects: 56
Study 32365398 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1500 mg/day)
Number of subjects: 45
Study 32365398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 35621282 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Iliotibial Band Tenodesis (MITBT)
Number of subjects: 164
Study 35621282 — intervention group
Group type: COMPARATOR
Intervention: Lateral Extracapsular Tenodesis (LET)
Number of subjects: 164
Study 32314120 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message reminders and data-informed counseling through 3 months postpartum
Number of subjects: 133
Study 32314120 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 133
Study 35039254 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine Paishi decoction combined with laparoscopic ureterectomy
Number of subjects: 100
Study 35039254 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic ureterectomy
Number of subjects: 100
Study 32494981 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 plus cisplatin (SP)
Number of subjects: 47
Study 32494981 — intervention group
Group type: COMPARATOR
Intervention: capecitabine plus cisplatin (XP)
Number of subjects: 47
Study 35129503 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS)‐guided lumen‐apposing metal stent (LAMS) with protocolized necrosectomy
Number of subjects: 40
Study 32578466 — intervention group
Group type: EXPERIMENTAL
Intervention: LVA ablation (group B, n=30)
Number of subjects: 398
Study 32578466 — intervention group
Group type: COMPARATOR
Intervention: No LVA ablation (group C, n=32)
Number of subjects: 398
Study 32578466 — intervention group
Group type: EXPERIMENTAL
Intervention: LVA ablation (group B)
Number of subjects: 398
Study 32578466 — intervention group
Group type: COMPARATOR
Intervention: No LVA ablation (group C)
Number of subjects: 398
Study 32425134 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic cannula (17-gauge inner needle)
Number of subjects: 16
Study 32425134 — intervention group
Group type: COMPARATOR
Intervention: Metal needle (16-gauge)
Number of subjects: 16
Study 32969562 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training
Number of subjects: 100
Study 32969562 — intervention group
Group type: COMPARATOR
Intervention: Coding training (active control)
Number of subjects: 100
Study 35279754 — intervention group
Group type: EXPERIMENTAL
Intervention: Attendance promotion intervention
Number of subjects: 2010
Study 35279754 — intervention group
Group type: COMPARATOR
Intervention: Self-employed participants
Number of subjects: 2010
Study 33328160 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycemic excursion minimization (GEM)
Number of subjects: 178
Study 33328160 — intervention group
Group type: COMPARATOR
Intervention: Conventional weight loss (WL)
Number of subjects: 178
Study 35508200 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 12
Study 35508200 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE)
Number of subjects: 12
Study 35508200 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise condition
Number of subjects: 12
Study 34703056 — intervention group
Group type: EXPERIMENTAL
Intervention: ultrasound guided SCPB with 5 mL ropivacaine 0.5%
Number of subjects: 30
Study 34703056 — intervention group
Group type: COMPARATOR
Intervention: Group 'No block'
Number of subjects: 30
Study 35971066 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - comprehensive assessment of physiological and psychological functioning, individual digital treatment program based on assessment needs
Number of subjects: 0
Study 35971066 — intervention group
Group type: COMPARATOR
Intervention: Active Control Group (ACG) - common digital treatment program aiming to reduce PACS symptoms
Number of subjects: 0
Study 35971066 — intervention group
Group type: COMPARATOR
Intervention: Comparison Group (CompG) - no treatment
Number of subjects: 0
Study 33890902 — intervention group
Group type: EXPERIMENTAL
Intervention: Nile tilapia fish skin
Number of subjects: 115
Study 33890902 — intervention group
Group type: COMPARATOR
Intervention: Silver sulfadiazine cream 1%
Number of subjects: 115
Study 32379676 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic Exercise (AE)
Number of subjects: 39
Study 32379676 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic Exercise + Massage (AM)
Number of subjects: 39
Study 32379676 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage (M)
Number of subjects: 39
Study 32379676 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 39
Study 34374434 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) with adjunctive amoxicillin (500 mg) and metronidazole (200 mg) three times a day for 7 days
Number of subjects: 14
Study 34374434 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) alone
Number of subjects: 14
Study 34110746 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination oral nitroimidazole 500 mg twice a day for 7 days and simultaneous boric acid 600 mg daily per vagina for 30 days, followed by twice-weekly vaginal metronidazole gel for 5 months.
Number of subjects: 105
Study 34110746 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance metronidazole gel
Number of subjects: 105
Study 34110746 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term follow-up
Number of subjects: 105
Study 32383271 — intervention group
Group type: EXPERIMENTAL
Intervention: THC (7.0% THC/0.18% CBD)
Number of subjects: 14
Study 32383271 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD (0.4% THC/10.4% CBD)
Number of subjects: 14
Study 32383271 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0% THC/0% CBD)
Number of subjects: 14
Study 32383271 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions (THC, CBD, Placebo)
Number of subjects: 14
Study 36226961 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial Group (TG)
Number of subjects: 66
Study 36226961 — intervention group
Group type: COMPARATOR
Intervention: No Trial Group (NTG)
Number of subjects: 66
Study 33581770 — intervention group
Group type: EXPERIMENTAL
Intervention: Collegial leadership practices/characteristics
Number of subjects: 3208
Study 33581770 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline collegial leadership
Number of subjects: 3208
Study 32903261 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral stimulation program (tactile extra-, peri-, and intraoral manipulation) once a day for 15 minutes over 10 days
Number of subjects: 74
Study 32903261 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral stimulation program
Number of subjects: 74
Study 32903261 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk intake
Number of subjects: 74
Study 616901046 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulants (DOACs) such as rivaroxaban and edoxaban
Number of subjects: 0
Study 616901046 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulants (DOACs)
Number of subjects: 0
Study 616901046 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 0
Study 35483708 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (OT)
Number of subjects: 0
Study 35483708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33494795 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetate Ringer’s solution
Number of subjects: 312
Study 33494795 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 312
Study 34032376 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive pedaling with mini bike, 20 min, twice a week for 3 months
Number of subjects: 37
Study 34032376 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 37
Study 32661707 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-vision
Number of subjects: 20
Study 32661707 — intervention group
Group type: COMPARATOR
Intervention: 2D-vision
Number of subjects: 20
Study 34157617 — intervention group
Group type: EXPERIMENTAL
Intervention: OxCapRT (oxaliplatin 85 mg/m2 on Days 1, 15, and 29; capecitabine 625 mg/m2 orally twice daily on days of radiotherapy)
Number of subjects: 85
Study 34157617 — intervention group
Group type: COMPARATOR
Intervention: CarPacRT (carboplatin AUC2; paclitaxel 50 mg/m2 on Days 1, 8, 15, 22, and 29)
Number of subjects: 85
Study 34157617 — intervention group
Group type: EXPERIMENTAL
Intervention: OxCapRT
Number of subjects: 85
Study 34157617 — intervention group
Group type: COMPARATOR
Intervention: CarPacRT
Number of subjects: 85
Study 32080093 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model for preoperative diagnosis of PM in gastric cancer
Number of subjects: 0
Study 32080093 — intervention group
Group type: COMPARATOR
Intervention: CT imaging (initial diagnosis as PM negative)
Number of subjects: 0
Study 35231721 — intervention group
Group type: EXPERIMENTAL
Intervention: ABRACADABRA instruction (16 hours over 8 weeks) with supplementary parent-led shared book reading
Number of subjects: 21
Study 35231721 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 21
Study 37086227 — intervention group
Group type: COMPARATOR
Intervention: No postprocedure prophylaxis (standard of care arm, group A)
Number of subjects: 139
Study 34656193 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure-only (EXP+EXP)
Number of subjects: 65
Study 34656193 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive strategies followed by exposure (COG+EXP)
Number of subjects: 65
Study 34656193 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation strategies followed by exposure (REL+EXP)
Number of subjects: 65
Study 34656193 — intervention group
Group type: COMPARATOR
Intervention: All conditions (EXP+EXP, COG+EXP, REL+EXP)
Number of subjects: 65
Study 32123973 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 43
Study 32123973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 35436940 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine (60 mg)
Number of subjects: 33
Study 35436940 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (1000 mg)
Number of subjects: 33
Study 35436940 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 33
Study 32167226 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-made PEKK posts
Number of subjects: 30
Study 32167226 — intervention group
Group type: COMPARATOR
Intervention: Conventional fiber posts
Number of subjects: 30
Study 32167226 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefabricated PEKK posts
Number of subjects: 30
Study 34751384 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanofibrous polymer‐based matrix
Number of subjects: 41
Study 34751384 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard of care such as Jelonet® or Biatain® Ibu dressing)
Number of subjects: 41
Study 33300239 — intervention group
Group type: EXPERIMENTAL
Intervention: Active, mandible protruded oral appliance (OAa)
Number of subjects: 71
Study 33300239 — intervention group
Group type: COMPARATOR
Intervention: Passive, mandible non‐protruded device (OAp)
Number of subjects: 71
Study 32475182 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary‐induced stepping response training (VSR)
Number of subjects: 34
Study 32475182 — intervention group
Group type: COMPARATOR
Intervention: DynSTABLE perturbation training (DST)
Number of subjects: 34
Study 32475182 — intervention group
Group type: COMPARATOR
Intervention: Both VSR and DST
Number of subjects: 34
Study 33983961 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted kinesio taping applied once a week for four sessions
Number of subjects: 62
Study 33983961 — intervention group
Group type: COMPARATOR
Intervention: Placebo taping application
Number of subjects: 62
Study 33983961 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted kinesio taping
Number of subjects: 62
Study 32894540 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin (Lep) at concentrations of 5-320 ng/mL
Number of subjects: 0
Study 35896277 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitor–based therapy (fixed combination of perindopril and indapamide)
Number of subjects: 9694
Study 35896277 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitor–based therapy
Number of subjects: 9694
Study 33871411 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder SMS texts
Number of subjects: 249
Study 33871411 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time medication monitoring (RTMM) device (Wisepill) with SMS reminders
Number of subjects: 249
Study 33871411 — intervention group
Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 249
Study 35565820 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarian/Vegan diets
Number of subjects: 436178
Study 35565820 — intervention group
Group type: COMPARATOR
Intervention: Omnivorous diets
Number of subjects: 436178
Study 35530564 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% TXA 1000 mg (10 mL) in 1 L of irrigation solution of sterile wash (glycine) during surgery
Number of subjects: 50
Study 35530564 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (placebo) in 1 L of irrigation solution of sterile wash (glycine) during surgery
Number of subjects: 50
Study 34350884 — intervention group
Group type: EXPERIMENTAL
Intervention: Zephyr valve
Number of subjects: 93
Study 34350884 — intervention group
Group type: COMPARATOR
Intervention: SoC
Number of subjects: 93
Study 33458967 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program (exercise + education, CRP cohort, n = 125)
Number of subjects: 492
Study 33458967 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise only (USC cohort, n = 182)
Number of subjects: 492
Study 33458967 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program (exercise + education, CRP cohort)
Number of subjects: 492
Study 36112108 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal social support
Number of subjects: 524
Study 36112108 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepregnancy OW/OB
Number of subjects: 524
Study 33921271 — intervention group
Group type: EXPERIMENTAL
Intervention: Loving-Kindness Meditation (LKM) training for 8 weeks
Number of subjects: 106
Study 33921271 — intervention group
Group type: COMPARATOR
Intervention: Waiting control group (no intervention)
Number of subjects: 106
Study 32453168 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve catheters placed perpendicular to the nerve (Group 1, n=40)
Number of subjects: 78